Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q2 2014 · 10-Q
Revenue$238.01K$238.01K−52.4% vs Q2 2013 Net Income$339.58K$339.58KN/M vs Q2 2013 EPS Diluted$0.00$0.00— vs Q2 2013 Gross Profit$190,746−55.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$387,207N/M Margins · derivedGross margin80.1%−5.8 pt vs Q2 2013
Net margin142.7%+173.7 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end